-
Professor Liang Aibin: Advances in Universal CAR-T Therapy | 2025 Conference on Cell Therapy and Biomedical Frontiers
Editor’s Note: Universal CAR-T cell therapy has emerged as one of the most dynamic frontiers in cellular immunotherapy. Characterized by its “off-the-shelf” availability and broad clinical potential, it has drawn…
-
CSCO Experts’ Insights │ Professor Fangjian Zhou: Guideline Updates and Quality Control System Drive China’s Renal Cancer Care to the Global Forefront
From September 10 to 14, 2025, the 28th Annual Meeting of the Chinese Society of Clinical Oncology (CSCO) was held in Jinan, Shandong. With the theme “Standardizing Diagnosis and Treatment, Leading Innovation”, the conference brought together leading domestic and international scholars. The Renal Cancer session featured the highly anticipated release of the 2025 CSCO Renal…
-
CSCO Key Highlights | Professor Jun Guo: CSCO and China’s Innovative Therapies Break Barriers and Reshape the Global Cancer Treatment Landscape
CSCO’s Growing Influence and Global Engagement Oncology Frontier: Over the years, CSCO has seen its academic influence steadily rise — helping Chinese experts “go global” while increasingly attracting international experts…
-
Nature Cancer | AI Foundation Model for Non-Invasive Prostate Cancer Diagnosis and Grading
Research Background Prostate cancer is the second most common malignancy among men worldwide. In China, its incidence has been rising steadily due to an aging population and increasingly Westernized lifestyles,…
-
A New Chapter in Comprehensive Management of Renal Cell Carcinoma | Professors Youyan Guan and Xiongjun Ye Provide In-Depth Insights
On August 22–23, 2025, the 2025 Pujiang Uro-Oncology Conference was held in Shanghai, bringing together leading experts to discuss advances in urologic oncology. This article is based on the pre-conference session presented by Professor Youyan Guan (Cancer Hospital, Chinese Academy of Medical Sciences) and Professor Xiongjun Ye, titled “Comprehensive Management of Renal Cancer Patients.” Their…
-
Transformative Advances in mHSPC Treatment Strategies
Editor’s Note: On August 22–23, 2025, the highly anticipated 2025 Pujiang Uro-Oncology Conference was held in Shanghai, gathering leading experts in urologic oncology from across China and abroad. Among the key topics was the optimization of treatment strategies for metastatic hormone-sensitive prostate cancer (mHSPC). Professor Xinan Sheng from Peking University Cancer Hospital delivered an insightful…
-
Good News | Academician Xu Zhang Elected Chair of ARUS, Professor Gang Zhu Elected Secretary-General
Recently, the Asian Robotic Urology Section (ARUS), one of the subspecialty committees under the Urological Association of Asia (UAA), held its leadership election and a chair handover ceremony during the UAA Annual Meeting. China’s Academician Xu Zhang has been officially elected as Chair of ARUS, and Professor Gang Zhu has been appointed Secretary-General.
-
Latest International Advances in Modern Lymphoma Treatment: Professor Qi Shunan Interprets Highlights of the ILROG Annual Meeting
Oncology Frontier – Hematology Frontier：As one of the organizers of this conference, which is a grand event in the international lymphoma radiation oncology field, can you briefly introduce the main…
Connecting Medical Expertise through Media